The Oncosearch | Oncotarget

Enhanced intratumoral expression of RNF2 is a favorable prognostic factor for patients with cutaneous melanoma? Research Paper

Åukasz KuÅºbicki, Dariusz Lange, Agata Stanek-Widera, Agnieszka GliÅ„ska, Barbara W. Chwirot

Published Apr 3, 2018 · Vol. 9, No. 25 · pp. 17656-17663

Molecular signatures associated with tumor-specific immune response in melanoma patients treated with dendritic cell-based immunotherapy Research Paper

Tamara GarcÃa-Salum, Andrea Villablanca, Franziska MatthÃ¤us, AndrÃ©s Tittarelli, Mauricio Baeza, CristiÃ¡n Pereda, M. Alejandra Gleisner, FermÃn E. GonzÃ¡lez, Mercedes N. LÃ³pez, JÃ¶rg D. Hoheisel, Johannes Norgauer, Peter J. Gebicke-Haerter, Flavio Salazar-Onfray

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 17014-17027

Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas Research Paper

Stefania Acciardo, Lionel Mignion, Nicolas Joudiou, Caroline Bouzin, Jean-FranÃ§ois Baurain, Bernard Gallez, BÃ©nÃ©dicte F. Jordan

Published Mar 30, 2018 · Vol. 9, No. 24 · pp. 16832-16846

Targeting oncogenic Ras by the Clostridium perfringens toxin TpeL Research Paper

BjÃ¶rn Schorch, Hannah Heni, Nour-Imene Zahaf, Tilman Brummer, Marina Mione, Gudula Schmidt, Panagiotis Papatheodorou, Klaus Aktories

Published Mar 27, 2018 · Vol. 9, No. 23 · pp. 16489-16500

Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study Research Paper

Taku Fujimura, Yota Sato, Kayo Tanita, Yumi Kambayashi, Atsushi Otsuka, Yasuhiro Fujisawa, Koji Yoshino, Shigeto Matsushita, Takeru Funakoshi, Hiroo Hata, Yuki Yamamoto, Hiroshi Uchi, Yumi Nonomura, Ryota Tanaka, Megumi Aoki, Keisuke Imafuku, Hisako Okuhira, Sadanori Furudate, Takanori Hidaka, Setsuya Aiba

Published Mar 20, 2018 · Vol. 9, No. 21 · pp. 15542-15551

Dynamic changes during the treatment of pancreatic cancer Research Paper

Robert A. Wolff, Andrea Wang-Gillam, Hector Alvarez, HervÃ© Tiriac, Dannielle Engle, Shurong Hou, Abigail F. Groff, Anthony San Lucas, Vincent Bernard, Kelvin Allenson, Jonathan Castillo, Dong Kim, Feven Mulu, Jonathan Huang, Bret Stephens, Ignacio I. Wistuba, Matthew Katz, Gauri Varadhachary, YoungKyu Park, James Hicks, Arul Chinnaiyan, Louis Scampavia, Timothy Spicer, Chiara Gerhardinger, Anirban Maitra, David Tuveson, John Rinn, Gregory Lizee, Cassian Yee, Arnold J. Levine

Published Mar 13, 2018 · Vol. 9, No. 19 · pp. 14764-14790

Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy Research Paper

Silvina Odete Bustos, Gustavo JosÃ© da Silva Pereira, Renata de Freitas Saito, Cristiane Damas Gil, Daniela Bertolli Zanatta, Soraya Soubhi Smaili, Roger Chammas

Published Mar 6, 2018 · Vol. 9, No. 18 · pp. 14567-14579

Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth in vitro and in vivo: a preliminary report Research Paper

Giovani M. Favero, Jessica L. Paz, AndrÃ©ia H. Otake, Durvanei A. Maria, Elia G. Caldini, Raphael S.S. de Medeiros, Debora F. Deus, Roger Chammas, Raul C. MaranhÃ£o, Sergio P. Bydlowski

Published Mar 6, 2018 · Vol. 9, No. 18 · pp. 14160-14174

The circadian clock regulates cisplatin-induced toxicity and tumor regression in melanoma mouse and human models Research Paper

Panshak P. Dakup, Kenneth I. Porter, Alexander A. Little, Rajendra P. Gajula, Hui Zhang, Elena Skornyakov, Michael G. Kemp, Hans P.A. Van Dongen, Shobhan Gaddameedhi

Published Mar 6, 2018 · Vol. 9, No. 18 · pp. 14524-14538

Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis Research Paper

Michael P. Marciel, Vedbar S. Khadka, Youping Deng, Pascal Kilicaslan, Andrew Pham, Pietro Bertino, Katie Lee, Suzie Chen, Natalija Glibetic, FuKun W. Hoffmann, Michelle L. Matter, Peter R. Hoffmann

Published Feb 3, 2018 · Vol. 9, No. 17 · pp. 13407-13422

Methotrexate sensitizes drug-resistant metastatic melanoma cells to BRAF V600E inhibitors dabrafenib and encorafenib Research Paper

Kayleigh C. Ross, Kevin F. Chin, Daehwan Kim, Christopher D. Marion, Timothy J. Yen, Vikram Bhattacharjee

Published Jan 29, 2018 · Vol. 9, No. 17 · pp. 13324-13336

Analysis of response rate with ANTI PD1/PD-L1 monoclonal antibodies in advanced solid tumors: a meta-analysis of randomized clinical trials Meta-Analysis

Alberto Carretero-GonzÃ¡lez, David Lora, Ismael Ghanem, Jon Zugazagoitia, Daniel Castellano, Juan Manuel SepÃºlveda, JosÃ© Antonio LÃ³pez-Martin, Luis Paz-Ares, Guillermo de Velasco

Published Jan 20, 2018 · Vol. 9, No. 9 · pp. 8706-8715

Percutaneous radiofrequency ablation in the treatment of pulmonary malignancies: efficacy, safety and predictive factors Research Paper

Tina Streitparth, Denis Schumacher, Robert Damm, Bjoern Friebe, Konrad Mohnike, Ortrud Kosiek, Maciej Pech, Jens Ricke, Florian Streitparth

Published Jan 18, 2018 · Vol. 9, No. 14 · pp. 11722-11733

Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models Research Paper

Kei Kawaguchi, Qinghong Han, Shukuan Li, Yuying Tan, Kentaro Igarashi, Kentaro Miyake, Tasuku Kiyuna, Masuyo Miyake, Bartosz Bartosz, Scott D. Nelson, Tara A. Russell, Sarah M. Dry, Yunfeng Li, Arun S. Singh, Mark A. Eckardt, Michiaki Unno, Fritz C. Eilber, Robert M. Hoffman

Published Jan 17, 2018 · Vol. 9, No. 13 · pp. 11119-11125

SCD5 restored expression favors differentiation and epithelial-mesenchymal reversion in advanced melanoma Research Paper

Rossella Puglisi, Maria Bellenghi, Giada Pontecorvi, Alessandro Gulino, Marina Petrini, Federica Felicetti, Lisabianca Bottero, Gianfranco Mattia, Alessandra CarÃ¨

Published Jan 9, 2018 · Vol. 9, No. 7 · pp. 7567-7581

Genetic alterations in main candidate genes during melanoma progression Research Paper

Maria Cristina Sini, Valentina Doneddu, Panagiotis Paliogiannis, Milena Casula, Maria Colombino, Antonella Manca, Gerardo Botti, Paolo A. Ascierto, Amelia Lissia, Antonio Cossu, Giuseppe Palmieri

Published Jan 3, 2018 · Vol. 9, No. 9 · pp. 8531-8541

Current status and perspectives in immunotherapy for metastatic melanoma Review

Riccardo Marconcini, Francesco Spagnolo, Luigia Stefania Stucci, Simone Ribero, Elena Marra, Francesco De Rosa, Virginia Picasso, Lorenza Di Guardo, Carolina Cimminiello, Stefano Cavalieri, Laura Orgiano, Enrica Tanda, Laura Spano, Alfredo Falcone, Paola Queirolo for the Italian Melanoma Intergroup (IMI)

Published Jan 3, 2018 · Vol. 9, No. 15 · pp. 12452-12470

Anorectal mucosal melanoma Review

Giulia Malaguarnera, Roberto Madeddu, Vito Emanuele Catania, Gaetano Bertino, Luca Morelli, Rosario Emanuele Perrotta, Filippo Drago, Michele Malaguarnera, Saverio Latteri

Published Jan 2, 2018 · Vol. 9, No. 9 · pp. 8785-8800

Selenium-binding protein 1 is down-regulated in malignant melanoma Research Paper

Mandy Schott, Miriam M. de Jel, Julia C. Engelmann, Philipp Renner, Edward K. Geissler, Anja K. Bosserhoff, Silke Kuphal

Published Jan 2, 2018 · Vol. 9, No. 12 · pp. 10445-10456

Cell-cell fusion as a mechanism of DNA exchange in cancer Research Paper

Stephen C. Searles, Endi K. Santosa, Jack D. Bui

Published Dec 27, 2017 · Vol. 9, No. 5 · pp. 6156-6173

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Enhanced intratumoral expression of RNF2 is a favorable prognostic factor for patients with cutaneous melanoma? Research Paper

Molecular signatures associated with tumor-specific immune response in melanoma patients treated with dendritic cell-based immunotherapy Research Paper

Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas Research Paper

Targeting oncogenic Ras by the Clostridium perfringens toxin TpeL Research Paper

Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study Research Paper

Dynamic changes during the treatment of pancreatic cancer Research Paper

Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy Research Paper

Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth in vitro and in vivo: a preliminary report Research Paper

The circadian clock regulates cisplatin-induced toxicity and tumor regression in melanoma mouse and human models Research Paper

Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis Research Paper

Methotrexate sensitizes drug-resistant metastatic melanoma cells to BRAF V600E inhibitors dabrafenib and encorafenib Research Paper

Analysis of response rate with ANTI PD1/PD-L1 monoclonal antibodies in advanced solid tumors: a meta-analysis of randomized clinical trials Meta-Analysis

Percutaneous radiofrequency ablation in the treatment of pulmonary malignancies: efficacy, safety and predictive factors Research Paper

Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models Research Paper

SCD5 restored expression favors differentiation and epithelial-mesenchymal reversion in advanced melanoma Research Paper

Genetic alterations in main candidate genes during melanoma progression Research Paper

Current status and perspectives in immunotherapy for metastatic melanoma Review

Anorectal mucosal melanoma Review

Selenium-binding protein 1 is down-regulated in malignant melanoma Research Paper

Cell-cell fusion as a mechanism of DNA exchange in cancer Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Enhanced intratumoral expression of RNF2 is a favorable prognostic factor for patients with cutaneous melanoma? Research Paper

Molecular signatures associated with tumor-specific immune response in melanoma patients treated with dendritic cell-based immunotherapy Research Paper

Imaging markers of response to combined BRAF and MEK inhibition in BRAF mutated vemurafenib-sensitive and resistant melanomas Research Paper

Targeting oncogenic Ras by the Clostridium perfringens toxin TpeL Research Paper

Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study Research Paper

Dynamic changes during the treatment of pancreatic cancer Research Paper

Galectin-3 sensitized melanoma cell lines to vemurafenib (PLX4032) induced cell death through prevention of autophagy Research Paper

Cell internalization of 7-ketocholesterol-containing nanoemulsion through LDL receptor reduces melanoma growth in vitro and in vivo: a preliminary report Research Paper

The circadian clock regulates cisplatin-induced toxicity and tumor regression in melanoma mouse and human models Research Paper

Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis Research Paper

Methotrexate sensitizes drug-resistant metastatic melanoma cells to BRAF V600E inhibitors dabrafenib and encorafenib Research Paper

Analysis of response rate with ANTI PD1/PD-L1 monoclonal antibodies in advanced solid tumors: a meta-analysis of randomized clinical trials Meta-Analysis

Percutaneous radiofrequency ablation in the treatment of pulmonary malignancies: efficacy, safety and predictive factors Research Paper

Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse models Research Paper

SCD5 restored expression favors differentiation and epithelial-mesenchymal reversion in advanced melanoma Research Paper

Genetic alterations in main candidate genes during melanoma progression Research Paper

Current status and perspectives in immunotherapy for metastatic melanoma Review

Anorectal mucosal melanoma Review

Selenium-binding protein 1 is down-regulated in malignant melanoma Research Paper

Cell-cell fusion as a mechanism of DNA exchange in cancer Research Paper